# Cero Therapeutics Holdings, Inc.: Form 8-K, filed Feb 4, 2026

- Company: [Cero Therapeutics Holdings, Inc.](/companies/cero.md) (CIK 1870404)
- Form: 8-K
- Filed: 2026-02-04
- Accepted by EDGAR: Feb 4, 2026, 14:12 ET
- Period: 2026-02-04
- Accession: 0001213900-26-011844
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1870404/000121390026011844/ea0275412-8k_cero.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1870404/000121390026011844/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1870404/000121390026011844/ea0275412-8k_cero.htm

Filed Feb 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-011844. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.